In the second half of 2025, the Taiwanese shareholders of TENFU (06868) have no intention of injecting the proceeds from the listing into the mainland China subsidiary, and will fully comply with cross-strait investment regulations.
Tien Fu (03759) announced that Taiwanese investors (including individuals and companies) must obtain approval from the Taiwan Investment Commission to make direct or indirect investments through companies controlled by them in the People's Republic of China.
TENFU (06868) announced that Taiwanese investors (including individuals and companies) are required to obtain approval from the Taiwan Investment Commission before making direct or indirect investments in the People's Republic of China (China) through companies controlled by them. According to the regulations on cross-strait investments, Taiwanese investors (including individuals and companies) are required to obtain prior approval from the Taiwan Investment Commission for direct or indirect investments in China through companies controlled by them. However, if all Taiwanese investors collectively invest a total amount not exceeding USD 1 million in a single Chinese entity, they will be allowed to submit a post-investment record to the Taiwan Investment Commission within six months after investing in that Chinese company.
As disclosed in the prospectus, the company has several Taiwanese founders, Mr. Li Ruihe and Mr. Zeng Mingshun (Taiwanese founders), and 81 Taiwanese original investors (81 Taiwanese original investors). They are required to comply with the above-mentioned cross-strait investment regulations when injecting the proceeds from listing their shares on the main board of the Hong Kong Stock Exchange into the company's Chinese subsidiary.
During the six months from July 1, 2025 to December 31, 2025, the company did not inject the proceeds from the listing into its Chinese subsidiary. The company gladly announces that it fully complied with the above-mentioned cross-strait investment regulations during the six months from July 1, 2025 to December 31, 2025.
Related Articles

Hunan Huamin Holdings (300345.SZ): Jinko Wuxi plans to increase its capital by 200 million yuan through debt-to-equity conversion for Hongxin New Energy.

BIOSINO BIO-TEC (08247) nominated Kang Rui as a non-executive director.

JIUMAOJIU (09922) spent 2.003 million Hong Kong dollars to repurchase 957,000 shares on January 22nd.
Hunan Huamin Holdings (300345.SZ): Jinko Wuxi plans to increase its capital by 200 million yuan through debt-to-equity conversion for Hongxin New Energy.

BIOSINO BIO-TEC (08247) nominated Kang Rui as a non-executive director.

JIUMAOJIU (09922) spent 2.003 million Hong Kong dollars to repurchase 957,000 shares on January 22nd.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


